Risk of end-stage renal disease in patients with type 1 diabetes

被引：0
作者：
Finne, P
Reunanen, A
Groop, PH
Grönhagen-Riska, C
机构：
[1] Finnish Registry Kidney Dis, Helsinki, Finland
[2] Natl Publ Hlth Inst, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V241 / V241
页数：1
相关论文
共 50 条
  • [41] The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus
    Postma, Maarten J.
    de Zeeuw, Dick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2975 - 2983
  • [42] Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease
    Sakai Y.
    Sakai S.
    Mugishima K.
    Katayama A.
    Sumi Y.
    Otsuka Y.
    Otsuka T.
    Tsuruoka S.
    Renal Replacement Therapy, 3 (1)
  • [43] The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes
    Zoungas, Sophia
    Kerr, Peter G.
    Lui, Michelle
    Teede, Helena J.
    NEPHROLOGY, 2008, 13 (02) : 124 - 127
  • [44] IMPACT OF DIABETES MELLITUS ON THE RISK OF END-STAGE RENAL DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ghafoor, Rabbiya
    Khan, Mehran
    Zaman, Abhar
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (06): : 5665 - 5669
  • [45] The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: Lessons from the RENAAL study
    Keane, WF
    Brenner, BM
    De Zeeuw, D
    Grunfeld, JP
    McGill, J
    Mitch, WE
    Ribeiro, AB
    Shahinfar, S
    Simpson, RL
    Snapinn, SM
    Toto, R
    DIABETES, 2002, 51 : A185 - A185
  • [46] Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus
    Ming-Yan Jiang
    Jyh-Chang Hwang
    I-Jung Feng
    Scientific Reports, 8
  • [47] Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus
    Jiang, Ming-Yan
    Hwang, Jyh-Chang
    Feng, I-Jung
    SCIENTIFIC REPORTS, 2018, 8
  • [48] The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease
    Mohideen, P
    Bornemann, M
    Sugihara, J
    Genadio, V
    Sugihara, V
    Arakaki, R
    ENDOCRINE, 2005, 28 (02) : 181 - 186
  • [49] The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease
    Pharis Mohideen
    Michael Bornemann
    Jared Sugihara
    Viola Genadio
    Valerie Sugihara
    Richard Arakaki
    Endocrine, 2005, 28 : 181 - 186
  • [50] Is preeclampsia a risk for end-stage renal disease?
    Ponticelli, Claudio
    Moroni, Gabriella
    KIDNEY INTERNATIONAL, 2019, 96 (03) : 547 - 549
12345